HER2-Positive Breast Cancer: A Review of Data from the SABCS 2021 Virtual Meeting

home / the-talk / the-talk-her2-positive-breast-cancer-a-review-of-data-from-the-sabcs-2021-virtual-meeting

Virginia Kaklamani, MD, DSc, shares her excitement for an upcoming OncLive® "The TALK" program focusing on HER2-positive breast cancer updates from the SABCS 2021 Virtual Meeting.